ATMI acquires Artelis in ‘disposables’ deal
ATMI has acquired Artelis, a Belgian biotech firm, in an effort to “get closer to customers” by widening its disposable technology portfolio to the life sciences research and manufacturing sector.
Archives for November 4, 2010
Epistem inks preclinical testing deal with NIH-funded project
An NIH funded radiation countermeasure programme has extended its preclinical testing services contract with Epistem for up to five years.